Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2022-05-31 00:00:00 ET · period of report 2022-05-26 · accession 0001367644-22-000088 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-31 | 2022-05-26 | EBS | Zoon Kathryn C | Dir | A - Grant | $0.00 | +8,446 | 20.8K | +68% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-26 | A | A | 8,446 | $0.00 | 20,827 | D | — | — | (F1) Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. (F2) These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company. |